JP2016537652A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016537652A5 JP2016537652A5 JP2016552704A JP2016552704A JP2016537652A5 JP 2016537652 A5 JP2016537652 A5 JP 2016537652A5 JP 2016552704 A JP2016552704 A JP 2016552704A JP 2016552704 A JP2016552704 A JP 2016552704A JP 2016537652 A5 JP2016537652 A5 JP 2016537652A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarkers
- expression
- binding
- sample
- pancreatic cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1319878.3 | 2013-11-11 | ||
| GBGB1319878.3A GB201319878D0 (en) | 2013-11-11 | 2013-11-11 | Method, Array and use thereof |
| PCT/GB2014/053340 WO2015067969A2 (en) | 2013-11-11 | 2014-11-11 | Method, array and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016537652A JP2016537652A (ja) | 2016-12-01 |
| JP2016537652A5 true JP2016537652A5 (enExample) | 2017-12-07 |
| JP6600637B2 JP6600637B2 (ja) | 2019-10-30 |
Family
ID=49818441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016552704A Expired - Fee Related JP6600637B2 (ja) | 2013-11-11 | 2014-11-11 | 膵臓がんを決定するための方法、アレイおよびそれらの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20160252513A1 (enExample) |
| EP (1) | EP3069143B1 (enExample) |
| JP (1) | JP6600637B2 (enExample) |
| KR (1) | KR102240473B1 (enExample) |
| CN (1) | CN105917230B (enExample) |
| AU (1) | AU2014345484B2 (enExample) |
| BR (1) | BR112016010510A2 (enExample) |
| CA (1) | CA2930211A1 (enExample) |
| ES (1) | ES2704888T3 (enExample) |
| GB (1) | GB201319878D0 (enExample) |
| MX (1) | MX2016006125A (enExample) |
| WO (1) | WO2015067969A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008231575A1 (en) | 2007-03-27 | 2008-10-02 | Immunovia Ab | Protein signature/markers for the detection of adenocarcinoma |
| GB201014837D0 (en) | 2010-09-07 | 2010-10-20 | Immunovia Ab | Biomarker signatures and uses thereof |
| GB201103726D0 (en) | 2011-03-04 | 2011-04-20 | Immunovia Ab | Method, array and use thereof |
| CN105021825B (zh) * | 2015-07-09 | 2016-08-17 | 陈勇 | 一种检测胰腺癌相关多肽dap44的elisa试剂盒 |
| GB201516801D0 (en) | 2015-09-22 | 2015-11-04 | Immunovia Ab | Method, array and use thereof |
| GB201608192D0 (en) | 2016-05-10 | 2016-06-22 | Immunovia Ab | Method, array and use thereof |
| GB201609950D0 (en) * | 2016-06-07 | 2016-07-20 | Immunovia Ab | Biomarkers signatures and uses thereof |
| GB201609951D0 (en) * | 2016-06-07 | 2016-07-20 | Immunovia Ab | Biomarkers signatures and uses thereof |
| EP3546943A4 (en) * | 2016-11-24 | 2020-09-16 | Huvet Bio, Inc. | DIAGNOSIS OF DISEASES |
| GB201701572D0 (en) * | 2017-01-31 | 2017-03-15 | Immunovia Ab | Methods, arrays and uses thereof |
| KR102536314B1 (ko) * | 2018-05-23 | 2023-05-25 | 주식회사 휴벳바이오 | 질환의 진단용 조성물 |
| US11487739B2 (en) | 2019-02-19 | 2022-11-01 | Nasdaq, Inc. | System and methods for data model detection and surveillance |
| CA3138991A1 (en) * | 2019-05-02 | 2020-11-05 | Ligandal, Inc. | Methods and compositions for diagnostically-responsive ligand-targeted delivery of therapeutic agents |
| WO2020235943A1 (ko) * | 2019-05-21 | 2020-11-26 | (주)아큐레시스바이오 | 암의 진단용 조성물 |
| GB202010970D0 (en) | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
| KR102226826B1 (ko) * | 2020-08-06 | 2021-03-11 | 주식회사 휴벳바이오 | 버피 코트 시료에 사용하기 위한 췌장암 진단용 조성물 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0039578B1 (en) | 1980-05-02 | 1985-04-10 | Edward P. Davis | Leg aid device |
| US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US5856090A (en) | 1994-09-09 | 1999-01-05 | The Scripps Research Institute | DNA-methylase linking reaction |
| GB9703369D0 (en) | 1997-02-18 | 1997-04-09 | Lindqvist Bjorn H | Process |
| US6727066B2 (en) * | 2000-07-28 | 2004-04-27 | Incyte Corporation | Genes expressed in treated human C3A liver cell cultures |
| WO2003087766A2 (en) * | 2002-04-05 | 2003-10-23 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Methods of diagnosing potential for metastasis or developing hepatocellular carcinoma and of identifying therapeutic targets |
| CN1703524B (zh) * | 2002-09-30 | 2010-04-07 | 肿瘤疗法科学股份有限公司 | 与人胰腺癌相关的基因和多肽 |
| US7250496B2 (en) * | 2002-11-14 | 2007-07-31 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory genes and uses thereof |
| US7217807B2 (en) * | 2002-11-26 | 2007-05-15 | Rosetta Genomics Ltd | Bioinformatically detectable group of novel HIV regulatory genes and uses thereof |
| CA2531118C (en) * | 2003-07-01 | 2013-01-08 | Immunomedics, Inc. | Multivalent carriers of bi-specific antibodies |
| KR101282396B1 (ko) * | 2004-05-28 | 2013-07-04 | 어젠시스 인코포레이티드 | Ｐｓｃａ 단백질에 결합하는 암 진단용 항체 |
| US8383357B2 (en) * | 2005-03-16 | 2013-02-26 | OSI Pharmaceuticals, LLC | Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors |
| CA2604844A1 (en) * | 2005-04-07 | 2006-10-19 | Novartis Vaccines And Diagnostics, Inc. | Cancer-related genes |
| JP2007051880A (ja) * | 2005-08-15 | 2007-03-01 | Tokyo Univ Of Science | 膵臓癌の検出方法、膵臓癌の診断キット |
| DK1974058T3 (da) * | 2006-01-11 | 2014-09-01 | Genomic Health Inc | Genekspressionsmarkører til prognosticering af kolorektal cancer |
| AU2008231575A1 (en) * | 2007-03-27 | 2008-10-02 | Immunovia Ab | Protein signature/markers for the detection of adenocarcinoma |
| WO2009006439A1 (en) * | 2007-06-29 | 2009-01-08 | Correlogic Systems, Inc. | Predictive markers for ovarian cancer |
| US7951549B2 (en) * | 2008-03-07 | 2011-05-31 | Osi Pharmaceuticals, Inc. | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
| GB0815846D0 (en) * | 2008-09-01 | 2008-10-08 | Immunovia Ab | diagnosis, prognosis and imaging of disease |
| PL3257953T3 (pl) * | 2009-03-12 | 2019-05-31 | Cancer Prevention & Cure Ltd | Sposoby identyfikacji, oceny, zapobiegania i terapii chorób płuc, ich zestawy, w tym do identyfikacji, oceny, zapobiegania i terapii chorób powiązanych z płcią |
| CA2775978A1 (en) * | 2009-09-29 | 2011-04-07 | Protagen Ag | Marker sequences for pancreatic cancer diseases, pancreatic carcinoma and use thereof |
| MY185582A (en) * | 2010-01-07 | 2021-05-24 | Malaysian Palm Oil Board | Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atheroslerosis and cardiovascular disease |
| CN102279264A (zh) * | 2010-06-09 | 2011-12-14 | 李彬 | 48种恶性肿瘤标志物抗体芯片的制备方法 |
| CN103299191B (zh) * | 2010-08-13 | 2016-06-15 | 莫尔豪斯医学院 | 中风的生物标记 |
| GB201103726D0 (en) * | 2011-03-04 | 2011-04-20 | Immunovia Ab | Method, array and use thereof |
| WO2012139628A1 (en) * | 2011-04-11 | 2012-10-18 | Lykera Biomed Sa | Coding polypurine hairpins for the treatment of cancer |
-
2013
- 2013-11-11 GB GBGB1319878.3A patent/GB201319878D0/en not_active Ceased
-
2014
- 2014-11-11 JP JP2016552704A patent/JP6600637B2/ja not_active Expired - Fee Related
- 2014-11-11 US US15/035,953 patent/US20160252513A1/en not_active Abandoned
- 2014-11-11 ES ES14815406T patent/ES2704888T3/es active Active
- 2014-11-11 AU AU2014345484A patent/AU2014345484B2/en not_active Ceased
- 2014-11-11 EP EP14815406.5A patent/EP3069143B1/en not_active Not-in-force
- 2014-11-11 MX MX2016006125A patent/MX2016006125A/es unknown
- 2014-11-11 KR KR1020167015574A patent/KR102240473B1/ko not_active Expired - Fee Related
- 2014-11-11 CA CA2930211A patent/CA2930211A1/en not_active Abandoned
- 2014-11-11 CN CN201480071589.2A patent/CN105917230B/zh not_active Expired - Fee Related
- 2014-11-11 WO PCT/GB2014/053340 patent/WO2015067969A2/en not_active Ceased
- 2014-11-11 BR BR112016010510A patent/BR112016010510A2/pt not_active IP Right Cessation
-
2018
- 2018-10-16 US US16/161,741 patent/US20190128891A1/en not_active Abandoned
-
2022
- 2022-03-25 US US17/704,057 patent/US20220214344A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kupcova Skalnikova et al. | Advances in proteomic techniques for cytokine analysis: focus on melanoma research | |
| de Hoog et al. | RNA and RNA binding proteins participate in early stages of cell spreading through spreading initiation centers | |
| JP2019516981A5 (enExample) | ||
| Zhou et al. | Statistical considerations of optimal study design for human plasma proteomics and biomarker discovery | |
| US12205677B2 (en) | System and method for analysis of biological data | |
| CN108034724B (zh) | 用于预测结直肠癌预后及死亡风险的环状rna分子标记物及其应用 | |
| JP2010522875A5 (enExample) | ||
| RU2018138639A (ru) | Способ, чип и их применение | |
| Nie et al. | Deep-dive targeted quantification for ultrasensitive analysis of proteins in nondepleted human blood plasma/serum and tissues | |
| JP2016519767A5 (enExample) | ||
| Schwenk et al. | Comparative protein profiling of serum and plasma using an antibody suspension bead array approach | |
| KR20230074025A (ko) | 세포 노화 바이오 마커 ac008012.1, cldn11, hmgn2, chaf1b 또는 klhl13, 및 이를 이용한 세놀리틱 약물을 스크리닝 하는 방법 | |
| CN104812914B (zh) | 诊断受试者中的肝癌的方法及诊断肝癌的试剂盒 | |
| US20230133776A1 (en) | Methods for diagnosing cancer | |
| JP2022553737A5 (enExample) | ||
| CN106011142A (zh) | 一种特异识别psa蛋白的寡核苷酸配基p7-26的序列和应用 | |
| JP2017529074A (ja) | 治療剤に対する抵抗性の診断に使用するためのＥＲＣＣ１アイソフォーム３のｍＲＮＡおよび／またはタンパク質ならびにこのｍＲＮＡおよび／またはタンパク質を使用する治療剤に対する抵抗性を診断するための方法 | |
| JP2017112849A (ja) | 老化マーカー及びその使用 | |
| CN205539001U (zh) | 检测蛋白质乙酰化水平的蛋白芯片及试剂盒 | |
| CN102713624B (zh) | 抗Ku86自身抗体的免疫测定方法、其中使用的试剂盒、及使用其的原发性肝细胞癌的判断方法 | |
| Meng et al. | Microfluidic Isolation of Aptamers for Intracellular Measurement of Radio-Responsive Proteins | |
| KR20260044139A (ko) | 높은 악성도의 위암 아형 진단용 바이오마커, 및 이를 이용한 예후 예측 방법 | |
| May | CCQM activities and impact in healthcare | |
| US20160097101A1 (en) | Aptamer specific to colorectal cancer cell and application thereof |